Verition Fund Management
IRWD icon

Verition Fund Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Verition Fund Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-74,330
Closed -$329K – 3511
2024
Q4 		$329K Buy
74,330
+56,905
+327% +$231K ﹤0.01% 2729
2024
Q3 		$71.8K Buy
+17,425
New +$93.7K ﹤0.01% 3028
2024
Q2 		– Sell
-56,583
Closed -$493K – 3125
2024
Q1 		$493K Buy
+56,583
New +$687K ﹤0.01% 2012
2023
Q4 		– Sell
-72,462
Closed -$698K – 2505
2023
Q3 		$698K Buy
72,462
+38,397
+113% +$376K 0.01% 1258
2023
Q2 		$362K Buy
+34,065
New +$366K ﹤0.01% 1423
2022
Q3 		– Sell
-19,707
Closed -$227K – 3133
2022
Q2 		$227K Sell
19,707
-248,819
-93% -$2.93M ﹤0.01% 1872
2022
Q1 		$3.38M Sell
268,526
-127,879
-32% -$1.47M 0.04% 608
2021
Q4 		$4.62M Buy
396,405
+345,912
+685% +$4.24M 0.03% 398
2021
Q3 		$659K Sell
50,493
-12,784
-20% -$165K 0.01% 1103
2021
Q2 		$815K Buy
+63,277
New +$724K 0.01% 888
2021
Q1 		– Sell
-41,815
Closed -$476K – 1647
2020
Q4 		$476K Buy
41,815
+27,894
+200% +$305K ﹤0.01% 681
2020
Q3 		$125K Buy
+13,921
New +$138K ﹤0.01% 978
2020
Q1 		– Sell
-11,044
Closed -$147K – 827
2019
Q4 		$147K Buy
+11,044
New +$122K ﹤0.01% 997
2019
Q2 		– Sell
-13,854
Closed -$157K – 1218
2019
Q1 		$157K Buy
+13,854
New +$155K 0.01% 994

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Verition Fund Management's IRWD Position: Q1 2025 in Review

Verition Fund Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 74,330 shares — an estimated $329K sold.

Verition Fund Management first reported a position in IRWD in Q1 2019 and held it in 14 quarters. The position peaked at $4.62M in Q4 2021. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • Verition Fund Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Verition Fund Management sold 74,330 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $329K.
  • Verition Fund Management first reported a position in Ironwood Pharmaceuticals in Q1 2019 and held it in 14 quarters.
  • Verition Fund Management's Ironwood Pharmaceuticals position peaked at $4.62M in Q4 2021.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.